Skip to main content
. 2020 Dec 24;99(4):115300. doi: 10.1016/j.diagmicrobio.2020.115300

Table 1.

Summary of days to seroconversion and patient outcomes.

n Days to seroconversion
P value
Median 95% CI Min Max IgG v IgM
All IgG 89 8 7–9 3 27 0.4194
IgM 88 7 6–8 2 76
Day of seroconversion caught IgG 41 8 7–10 4 19 0.9533
IgM 34 8 7–10 4 17
Male IgG 53 8 6–10 3 24 0.1705 Male v Female IgG
IgM 52 7 6–8 2 74 0.0757
Female IgG 36 8 6–9 3 15 0.4768 Male v Female IgM
IgM 36 6 5–8 3 15 0.2358
Survived IgG 69 8 6–10 3 27 0.2938 Survived v Died IgG
IgM 68 6 6–8 2 76 0.5517
Deceased IgG 20 7.5 6–9 5 18 0.6993 Survived v Died IgM
IgM 19 8 6–10 3 18 0.4941
Immune competent IgG 80 7.5 6–8 3 27 0.1974 Competent v Compromised IgG
IgM 79 6 6–7 2 27 0.0004
Immune compromised IgG 9 15 11–20 11 20 0.2531 Competent v Compromised IgM
IgM 8 17.5 11–76 11 76 <0.0001
<65 years old IgG 40 11 9–12 4 27 0.5442 Older v younger IgG
IgM 39 8.5 7–12 3 27 <0.0001
≥65 years old IgG 49 6 5–8 3 14 0.6322 Older v younger IgM
IgM 49 6 4–7 2 76 0.0008